Isopropyl alcohol 0.7 ML/ML Medicated Pad — RxCUI 797544
RxNorm drug concept · Semantic clinical drug
RxCUI 797544
Semantic clinical drug · SCD
● Current RxNorm concept 496 FDA products
698 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI797544
Official nameIsopropyl alcohol 0.7 ML/ML Medicated Pad
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asisopropyl alcohol 70 % Topical Swab; isopropyl alcohol 70 % Medicated Pad; isopropyl alcohol 70 % Topical Cloth
FDA products mapped496
Package NDCs mapped698
Reported Medicaid activity (SDUD)516,671 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Isopropyl alcohol 0.7 ML/ML Medicated Pad Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Isopropyl alcohol 0.7 ML/ML Medicated Pad
RxCUI 797544 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Isopropyl alcohol
797541IN
-
Isopropyl alcohol
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Isopropyl alcohol Medicated Pad
798531SCDF -
Isopropyl alcohol Medicated Pad or Tape
1159742SCDG -
Isopropyl alcohol Topical Product
1159744SCDG -
Medicated Pad
797271DF -
Medicated Pad or Tape
1151124DFG -
Topical Product
1151122DFG
-
Isopropyl alcohol Medicated Pad
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Isopropyl alcohol 0.7 ML/ML
797542SCDC
-
Isopropyl alcohol 0.7 ML/ML
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Isopropyl alcohol 0.7 ML/ML
SCDC · 797542 -
Isopropyl alcohol Medicated Pad
SCDF · 798531 -
Isopropyl alcohol Medicated Pad or Tape
SCDG · 1159742 -
Isopropyl alcohol Topical Product
SCDG · 1159744
📦 FDA Products & Package NDCs
496 products · 698 package NDCs
698 package NDCs map to RxCUI 797544 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00025-0325-01 | 1 KIT in 1 CARTON (0025-0325-01) / 1 KIT in 1 KIT * .8 mL... | ABRILADA | Pfizer Laboratories Div Pfizer Inc | 2023-12-14 |
| 00025-0325-02 | 2 KIT in 1 CARTON (0025-0325-02) / 1 KIT in 1 KIT * .8 mL... | ABRILADA | Pfizer Laboratories Div Pfizer Inc | 2023-12-14 |
| 00025-0328-02 | 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRI... | ABRILADA | Pfizer Laboratories Div Pfizer Inc | 2023-12-14 |
| 00025-0333-02 | 2 KIT in 1 CARTON (0025-0333-02) / 1 KIT in 1 KIT * 1 SYRI... | ABRILADA | Pfizer Laboratories Div Pfizer Inc | 2023-12-14 |
| 00074-0124-01 | 1 KIT in 1 CARTON (0074-0124-01) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2017-04-21 |
| 00074-0124-02 | 2 KIT in 1 CARTON (0074-0124-02) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2020-12-16 |
| 00074-0124-03 | 3 KIT in 1 CARTON (0074-0124-03) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2017-04-21 |
| 00074-0124-04 | 4 KIT in 1 CARTON (0074-0124-04) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2021-02-24 |
| 00074-0124-74 | 1 KIT in 1 CARTON (0074-0124-74) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2017-04-21 |
| 00074-0243-02 | 2 KIT in 1 CARTON (0074-0243-02) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2015-11-23 |
| 00074-0554-01 | 1 KIT in 1 CARTON (0074-0554-01) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2016-03-09 |
| 00074-0554-02 | 2 KIT in 1 CARTON (0074-0554-02) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2016-03-09 |
| 00074-0554-71 | 2 KIT in 1 CARTON (0074-0554-71) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2016-03-09 |
| 00074-0554-74 | 1 KIT in 1 CARTON (0074-0554-74) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2016-03-09 |
| 00074-0616-02 | 2 KIT in 1 CARTON (0074-0616-02) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2017-04-28 |
| 00074-0616-71 | 2 KIT in 1 CARTON (0074-0616-71) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2017-04-28 |
| 00074-0817-02 | 2 KIT in 1 CARTON (0074-0817-02) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2017-04-28 |
| 00074-1050-01 | 1 SYRINGE in 1 CARTON (0074-1050-01) / 1 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2021-04-26 |
| 00074-1050-70 | 1 SYRINGE in 1 CARTON (0074-1050-70) / 1 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2021-04-26 |
| 00074-1065-01 | 1 KIT in 1 CARTON (0074-1065-01) * 1.2 mL in 1 CARTRIDGE (... | Skyrizi | AbbVie Inc. | 2022-09-23 |
| 00074-1065-02 | 1 KIT in 1 CARTON (0074-1065-02) * 1.2 mL in 1 CARTRIDGE (... | Skyrizi | AbbVie Inc. | 2022-09-23 |
| 00074-1070-01 | 1 KIT in 1 CARTON (0074-1070-01) * 2.4 mL in 1 CARTRIDGE (... | Skyrizi | AbbVie Inc. | 2022-06-16 |
| 00074-1070-02 | 1 KIT in 1 CARTON (0074-1070-02) * 2.4 mL in 1 CARTRIDGE (... | Skyrizi | AbbVie Inc. | 2022-06-16 |
| 00074-1539-03 | 3 KIT in 1 CARTON (0074-1539-03) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2017-04-21 |
| 00074-2100-01 | 1 SYRINGE in 1 CARTON (0074-2100-01) / 1 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2021-04-26 |
| 00074-2100-70 | 1 SYRINGE in 1 CARTON (0074-2100-70) / 1 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2021-04-26 |
| 00074-2540-01 | 1 KIT in 1 CARTON (0074-2540-01) / 1 KIT in 1 KIT * 1 mL i... | Humira | AbbVie Inc. | 2016-10-17 |
| 00074-3641-03 | 1 KIT in 1 CARTON (0074-3641-03) * 1 mL in 1 SYRINGE * 1... | Lupron Depot | AbbVie Inc. | 1990-10-22 |
| 00074-3641-71 | 1 KIT in 1 CARTON (0074-3641-71) * 1 mL in 1 SYRINGE * 1... | Lupron Depot | AbbVie Inc. | 1990-10-22 |
| 00074-3799-02 | 2 KIT in 1 CARTON (0074-3799-02) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2002-12-31 |
| 00074-4059-01 | 1 SYRINGE, GLASS in 1 CARTON (0074-4059-01) / .37 mL in 1 S... | Skyrizi | AbbVie Inc. | 2026-06-12 |
| 00074-4059-71 | 1 SYRINGE, GLASS in 1 CARTON (0074-4059-71) / .37 mL in 1 S... | Skyrizi | AbbVie Inc. | 2026-06-12 |
| 00074-4339-02 | 2 KIT in 1 CARTON (0074-4339-02) / 1 KIT in 1 KIT * 1 SYRI... | Humira | AbbVie Inc. | 2006-06-23 |
| 00074-5015-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-5015-01) / 10 mL in 1... | Skyrizi | AbbVie Inc. | 2022-06-16 |
| 00074-5015-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-5015-02) / 10 mL in 1... | Skyrizi | AbbVie Inc. | 2022-06-16 |
| 00074-7040-02 | 2 CARTON in 1 CARTON (0074-7040-02) / 1 KIT in 1 CARTON *... | Skyrizi | AbbVie Inc. | 2024-03-04 |
| 00074-7042-04 | 4 CARTON in 1 CARTON (0074-7042-04) / 1 KIT in 1 CARTON *... | Skyrizi | AbbVie Inc. | 2024-03-04 |
| 00074-8300-01 | 1 SYRINGE in 1 CARTON (0074-8300-01) / 1.2 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2025-09-03 |
| 00074-8350-01 | 2 SYRINGE in 1 CARTON (0074-8350-01) / 1.2 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2025-09-03 |
| 00121-2106-02 | 1 KIT in 1 CARTON (0121-2106-02) * 1 VIAL, MULTI-DOSE in 1... | leuprolide acetate | PAI Holdings, LLC dba PAI Pharma | 2025-02-01 |
| 00363-0809-30 | 100 PACKET in 1 BOX (0363-0809-30) / 1 APPLICATOR in 1 PACK... | Walgreen Alcohol | Walgreens Company | 2011-01-01 |
| 00363-0809-60 | 200 PACKET in 1 BOX (0363-0809-60) / 1 APPLICATOR in 1 PACK... | Walgreen Alcohol | Walgreens Company | 2011-01-01 |
| 00363-0809-86 | 400 PACKET in 1 BOX (0363-0809-86) / 1 APPLICATOR in 1 PACK... | Walgreen Alcohol | Walgreens Company | 2011-01-01 |
| 00363-6505-00 | 40 PATCH in 1 CANISTER (0363-6505-00) / 4.7 mL in 1 PATCH | Walgreens 70% Isopropyl Alcohol Wipes | Walgreen Company | 2017-06-15 |
| 00404-0007-02 | 200 PACKET in 1 CARTON (0404-0007-02) / 1 mL in 1 PACKET | Alcohol Prep Pads | Henry Schein, Inc. | 2015-10-27 |
| 00404-0103-02 | 200 PACKET in 1 BOX (0404-0103-02) / 1 mL in 1 PACKET | Alcohol Prep Pads | Henry Schein, Inc. | 2021-01-01 |
| 00404-9406-02 | 200 PATCH in 1 BOX (0404-9406-02) / .34 mL in 1 PATCH | Alcohol Prep Pad Large Pad | Henry Schein Inc. | 2021-01-01 |
| 00404-9407-02 | 200 PATCH in 1 BOX (0404-9407-02) / .68 mL in 1 PATCH | Alcohol Prep Pad Medium Pad | Henry Schein Inc. | 2021-01-01 |
| 00404-9408-02 | 200 POUCH in 1 BOX (0404-9408-02) / .34 mL in 1 POUCH | Alcohol Prep Pad Medium Pad | Henry Schein Inc. | 2021-04-01 |
| 00536-1103-01 | .4 mL in 1 POUCH (0536-1103-01) | Alcohol Prep Pad | Rugby Laboratories | 2017-04-05 |
Observed labelers:
Sarepta Therapeutics, Inc. (61) ·
Novartis Innovative Technologies Inc. (37) ·
AbbVie Inc. (35) ·
Shandong Haiyan Medical Manufacture Co., Ltd. (29) ·
Medline Industries, LP (24) ·
Asclemed USA, Inc. (21)
· +163 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3402 | Inj. remestemcel-l-rknd/ td | 9 | CMS |
| J1950 | Leuprolide acetate /3.75 mg | 1 | CMS |
| J2327 | Inj risankizumab-rzaa 1 mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.